194 related articles for article (PubMed ID: 9009112)
1. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit.
O'Brien MD; Camilleri M; Thomforde GM; Wiste JA; Hanson RB; Zinsmeister AR
Dig Dis Sci; 1997 Jan; 42(1):26-33. PubMed ID: 9009112
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin stimulates neuronal receptors to produce contraction of the canine colon.
Barone FC; Bondinell WE; Labosh TJ; White RF; Ormsbee HS
Life Sci; 1989; 44(8):533-42. PubMed ID: 2927258
[TBL] [Abstract][Full Text] [Related]
3. Regional effects of cholecystokinin octapeptide on colonic phasic and tonic motility in healthy humans.
Coffin B; Fossati S; Flourié B; Lémann M; Jouet P; Franchisseur C; Jian R; Rambaud JC
Am J Physiol; 1999 Mar; 276(3):G767-72. PubMed ID: 10070055
[TBL] [Abstract][Full Text] [Related]
4. The effects of cholecystokinin-octapeptide and pentagastrin on electrical and motor activities of canine colonic circular muscle.
Huizinga JD; Chang G; Diamant NE; el-Sharkawy TY
Can J Physiol Pharmacol; 1984 Dec; 62(12):1440-7. PubMed ID: 6099217
[TBL] [Abstract][Full Text] [Related]
5. SDZ HTF 919 stimulates canine colonic motility and transit in vivo.
Nguyen A; Camilleri M; Kost LJ; Metzger A; Sarr MG; Hanson RB; Fett SL; Zinsmeister AR
J Pharmacol Exp Ther; 1997 Mar; 280(3):1270-6. PubMed ID: 9067313
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans.
Fraser R; Fone D; Horowitz M; Dent J
Gut; 1993 Jan; 34(1):33-7. PubMed ID: 8432448
[TBL] [Abstract][Full Text] [Related]
7. Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide.
Kellow JE; Miller LJ; Phillips SF; Haddad AC; Zinsmeister AR; Charboneau JW
Am J Physiol; 1987 Mar; 252(3 Pt 1):G345-56. PubMed ID: 3826375
[TBL] [Abstract][Full Text] [Related]
8. Control of muscle tone in the human colon.
Steadman CJ; Phillips SF; Camilleri M; Talley NJ; Haddad A; Hanson R
Gut; 1992 Apr; 33(4):541-6. PubMed ID: 1582599
[TBL] [Abstract][Full Text] [Related]
9. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide is involved in the inhibitory action of cholecystokinin octapeptide (CCK-OP) on proximal colonic motility.
Machino H; Kobayashi H; Hayashi K; Tawara Y; Ito M; Kishimoto S
Regul Pept; 1997 Mar; 69(1):47-52. PubMed ID: 9163582
[TBL] [Abstract][Full Text] [Related]
11. Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations.
Bazzocchi G; Ellis J; Villanueva-Meyer J; Reddy SN; Mena I; Snape WJ
Gastroenterology; 1991 Nov; 101(5):1298-306. PubMed ID: 1936800
[TBL] [Abstract][Full Text] [Related]
12. Beta adrenergic influence on esophageal and colonic motility in man.
Lyrenäs E
Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
[TBL] [Abstract][Full Text] [Related]
13. Role of hypothalamic cholecystokinin octapeptide in the colonic motor response to a meal in rats.
Liberge M; Arruebo MP; Bueno L
Gastroenterology; 1991 Feb; 100(2):441-9. PubMed ID: 1985040
[TBL] [Abstract][Full Text] [Related]
14. Association between postprandial changes in colonic intraluminal pressure and transit.
Moreno-Osset E; Bazzocchi G; Lo S; Trombley B; Ristow E; Reddy SN; Villanueva-Meyer J; Fain JW; Jing J; Mena I
Gastroenterology; 1989 May; 96(5 Pt 1):1265-73. PubMed ID: 2703114
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans.
Law NM; Bharucha AE; Undale AS; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2001 Nov; 281(5):G1228-37. PubMed ID: 11668032
[TBL] [Abstract][Full Text] [Related]
16. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.
Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.
Acosta A; Camilleri M; Busciglio I; Boldingh A; Nelson AD; Burton D
Dig Dis Sci; 2016 Mar; 61(3):852-60. PubMed ID: 26467700
[TBL] [Abstract][Full Text] [Related]
18. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.
Talley NJ; Phillips SF; Haddad A; Miller LJ; Twomey C; Zinsmeister AR; MacCarty RL; Ciociola A
Dig Dis Sci; 1990 Apr; 35(4):477-80. PubMed ID: 2138532
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs.
Kuwahara A; Ozawa K; Yanaihara N
Am J Physiol; 1986 Nov; 251(5 Pt 1):G678-81. PubMed ID: 2877583
[TBL] [Abstract][Full Text] [Related]
20. Effect of CCK-OP and intraduodenal administration of essential amino acids on intraluminal pressures of sigmoid and rectum in patients with Chagasic megacolon.
Macedo JF; Meneghelli UG; Oliveira RB; Godoy RA; Troncon LE; Dantas RO
Dig Dis Sci; 1986 Feb; 31(2):145-50. PubMed ID: 3080277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
